Trials / Completed
CompletedNCT00247364
A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Sleep Health Centers · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To define the effective dose and tolerability of levetiracetam in individuals with Restless Legs Syndrome (RLS). It is hypothesized that levetiracetam will be well tolerated, safe and effective in treating the symptoms of RLS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam (Keppra) |
Timeline
- Start date
- 2003-11-01
- Completion
- 2005-10-01
- First posted
- 2005-11-01
- Last updated
- 2005-11-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00247364. Inclusion in this directory is not an endorsement.